However, it is unknown whether the OAS gene family actually plays a beneficial or harmful role in SARS-CoV-2-infected cardiomyocytes and COVID-19-induced cardiac injury and failure, as activations of antiviral genes do not necessarily produce a beneficial effect on the viral diseases such as COVID-19 [22, 23]. This evidence concerns the gene SMOC1 and COVID-19.